Delivery Order SPE2DR25D7062-SPE2DR26FW9RT
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,472.63 to AmerSourceBergen Drug Corp on January 7, 2026, for pharmaceutical products and medical supplies to support federal healthcare operations. The award is a non-set-aside, competitively awarded delivery order under a firm fixed-price contract structure, with performance scheduled for completion by January 8, 2026. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- This delivery order, awarded on January 7, 2026, represents a $1,663.68 firm fixed-price purchase of pharmaceutical products from AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc. The award was issued by the Defense Logistics Agency's Medical Supply Chain, with a completion date of January 8, 2026. The contract utilizes a non-set-aside competitive procurement process, reflecting the vendor's qualification to compete on a full and open basis for federal medical supply requirements. The...
- This delivery order, awarded on January 6, 2026, to AmerSourceBergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency's Medical Supply Chain, carries a ceiling value of $3,896.70 and is scheduled for ultimate completion by January 7, 2026. The award is a firm fixed-price delivery order with no set-aside designation, reflecting open and competitive procurement. The contractor is based in Conshohocken, Pennsylvania, where AmerSourceBergen maintains its corporate office and...
- This delivery order, awarded January 7, 2026, to AmerSourceBergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency Medical Supply Chain, represents a $15,514.03 firm fixed-price contract with an ultimate completion date of January 8, 2026. The award is not set-aside and was competitively awarded. AmerSourceBergen will perform this contract at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $83,146.17 to AmerSourceBergen Drug Corp on January 8, 2026, with an ultimate completion date of January 9, 2026. This non-set-aside competitive award is a child contract issued under AmerSourceBergen's parent company Cencora, Inc., and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is Conshohocken, Pennsylvania, where AmerSourceBergen's corporate...
- This delivery order, valued at $2,356.08, was awarded on January 7, 2026, to AmerSourceBergen Drug Corp (CAGE 0U9U0), a subsidiary of Cencora, Inc., for pharmaceutical and medical supply delivery with completion expected by January 8, 2026. The award was funded by the Defense Logistics Agency's Medical Supply Chain and performed at the company's corporate office in Conshohocken, Pennsylvania. This delivery order represents a competitively awarded, firm fixed-price transaction executed under a...
- The Defense Logistics Agency awarded a $31,536.30 delivery order to AmerSourceBergen Drug Corp on January 7, 2026, for pharmaceutical products and medical supplies supporting federal healthcare systems. This firm fixed-price, competitively awarded delivery order is scheduled for completion by January 29, 2026, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerSourceBergen's parent...
- This delivery order, awarded January 6, 2026, provides $10,009.14 in firm fixed-price pharmaceutical supplies to AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., through the Defense Logistics Agency's Medical Supply Chain. The award represents a single delivery order with an ultimate completion date of January 7, 2026, and carries no set-aside designation, indicating it was competitively awarded. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $8,555.21 to AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued without a set-aside designation, represents a task order executed under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999.999 billion through December 2026. The contract supports federal medical...
- This delivery order, valued at $1.72M and issued on January 8, 2026, was awarded to AmerSourceBergen Drug Corp (subsidiary of parent company Cencora, Inc.) by the Defense Logistics Agency's Medical Supply Chain. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award based on capability. Performance will be executed from the awardee's Conshohocken, Pennsylvania location, with an ultimate completion date of January 9, 2026. This delivery order...
- SPE2DR25D7062Indefinite Delivery Contract
- SPE2DR25D7062-SPE2DR26FW9RTDelivery Order
This delivery order, valued at $2,119.26, was awarded to AmerSourceBergen Drug Corp on January 8, 2026, by the Defense Logistics Agency (DLA) under a competitive, non-set-aside procurement. The award represents a task order issued against AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999,999,999.00 and extending through December 31, 2031. This contract vehicle provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, medical devices, and other critical healthcare commodities across multiple therapeutic domains. The delivery order is structured as a firm fixed-price purchase utilizing a competitively awarded contract vehicle that demonstrates AmerSourceBergen's established capability to meet federal pharmaceutical procurement requirements. The place of performance is Conshohocken, Pennsylvania, where AmerSourceBergen Drug Corp maintains its corporate office. The ultimate completion date of January 8, 2026, indicates this is a near-term delivery requirement supporting military treatment facilities, veterans' healthcare programs, and other federal medical institutions through DLA's established pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 1/7/26 |